Trade
Hester Biosciences share price
Balanced risk
You have to be logged in to add this to Watchlist.- ₹2,109.40(0.73%)July 10, 2026 15:24:05 PM IST
- NSE
- BSE
- Vol : 3.61 K (NSE + BSE)Last 20 day avg : 10.77 K
Hester Biosciences is trading 0.73% upper at Rs 2,109.40 as compared to its last closing price. Hester Biosciences has been trading in the price range of 2,144.35 & 2,102.35. Hester Biosciences has given 31.41% in this year & -2.99% in the last 5 days. The company posted a net profit of 15.98 Crores in its last quarter.Listed peers of Hester Biosciences include Sun Pharmaceutical Industries (-0.19%), Cipla (-0.20%), Divi's Laboratories (0.31%).The Mutual Fund holding in Hester Biosciences was at 0.03% in 31 Dec 2022. The MF holding has decreased from the last quarter. The FII holding in Hester Biosciences was at 0.38% in 31 Mar 2026. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Key Metrics
Updated on Jul 10, 2026, 05:37 PM UTC
- BetaHigh volatility1.31Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Dividend YieldLower than industry0.52Annual dividends as a percentage of the stock price.
- PEG RatioIndicates Fair Valuation1.41The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- Debt To Equity-The debt-to-equity ratio, indicating a company's financial leverage.
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Hester Biosciences News
Hester Biosciences Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,935.25 | -0.19 | 4,64,320.36 | 36.24 | 5.77 | 0.92 | 0.50 |
| Cipla | 1,438.75 | -0.20 | 1,16,228.75 | 22.95 | 3.87 | 0.87 | 0.81 |
| Divi's Laboratories | 6,832.30 | 0.31 | 1,81,268.32 | 78.61 | 11.52 | 0.46 | 0.01 |
| Dr Reddy's Laboratories | 1,245.50 | -1.91 | 1,03,954.01 | 18.63 | 3.14 | 0.63 | 2.34 |
| Torrent Pharmaceuticals | 4,895.20 | -0.03 | 1,65,669.16 | 67.32 | 17.1 | 0.83 | 17.62 |
Mutual Fund Ownership
View allHester Biosciences Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-05-15 | Audited Results & Final Dividend |
| 2026-01-30 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-01 | Quarterly Results |
| 2025-05-09 | Audited Results & Final Dividend |
About the company Hester Biosciences
- IndustryBiotechnology & Drugs
- ISININE782E01017
- BSE Code524669
- NSE CodeHESTERBIO
Hester Biosciences Limited is an India-based animal healthcare company. The Company is principally engaged in manufacturing poultry vaccines, large animal vaccines, and trading poultry, large animal, and petcare health products. It operates through three segments: Poultry Healthcare, Animal Healthcare, and Petcare. The Poultry Healthcare vaccines include Gumboro I, Inactivated Chick ND, Inactivated Coryza, Inactivated EDS, Inactivated FC3, Inactivated FC4, Inactivated IB, and Inactivated IBD. The Animal Healthcare vaccines include Goat Pox Vaccine, Live Brucella, PPR Vaccine - Nigerian 75/1, and PPR Vaccine - Sungri/96. Its Petcare products include Cefshot Tazo Injection, Hestacef CV, Hestacef DS, Pawfresh, Synoton, Petsglow, and Vitacoat. The Company also operates diagnostic labs for poultry and provides diagnostic kits for sero-surveillance and mastitis prevention for cattle farms. Its manufacturing facility is located at Meda Adraj Village, Mehsana District, Gujarat.
Hester Biosciences Share Price FAQs
Hester Biosciences is trading at 2109.40 as on Fri Jul 10 2026 09:54:05. This is 0.73% upper as compared to its previous closing price of 2094.20.
The market capitalization of Hester Biosciences is 1793.88 Cr as on Fri Jul 10 2026 09:54:05.
The 52 wk high for Hester Biosciences is 2347.70 whereas the 52 wk low is 1250.95
Hester Biosciences can be analyzed on the following key metrics -
- TTM P/E: 23.53
- Sector P/E: -
- Dividend Yield: 0.52%
- D/E ratio: 0.54
Hester Biosciences reported a net profit of 55.64 Cr in 2026.
The Mutual Fund Shareholding was 0.03% at the end of 31 Dec 2022.
Quick Links
EQUITY QUICK LINKS
Hester Biosciences QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.